DiRaimondo Thomas
Janux Therapeutics, Inc. · Chief Scientific Officer
DiRaimondo Thomas is listed in public filings as officer: Chief Scientific Officer. This DiRaimondo Thomas insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Janux Therapeutics, Inc. (JANX). Investors use DiRaimondo Thomas's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.5M109.9k shares | Grant / ExerciseJan 2, 2026 | $1.5M109.9k shares | $13.65 | -- | |
| --155.8k shares | Grant / ExerciseJan 2, 2026 | Disclosure amount unavailable31.4k shares | -- | -- | |
| $1.7M124.4k shares | SellJan 2, 2026 | $34.4K2.5k shares | $13.73 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $4.5M84k shares | Grant / ExerciseJan 2, 2025 | $4.5M84k shares | $53.24 | -- | |
| --129.7k shares | Grant / ExerciseJan 2, 2025 | Disclosure amount unavailable24k shares | -- | -- | |
| $4.6M98.6k shares | SellSep 27, 2024 | $199.8K4.3k shares | $46.21 | -- | |
| $4.6M97.9k shares | SellSep 27, 2024 | $31.9K675 shares | $47.22 | -- |